Superoxide dismutase

Revision as of 20:05, 1 July 2009 by Mdoherty (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Structure of the monomeric unit of human superoxide dismutase 2
superoxide dismutase 1, soluble
Identifiers
SymbolSOD1
Alt. symbolsALS, ALS1
Entrez6647
HUGO11179
OMIM147450
RefSeqNM_000454
UniProtP00441
Other data
EC number1.15.1.1
LocusChr. 21 q22.1
superoxide dismutase 2, mitochondrial
Identifiers
SymbolSOD2
Entrez6648
HUGO11180
OMIM147460
RefSeqNM_000636
UniProtP04179
Other data
EC number1.15.1.1
LocusChr. 6 q25
superoxide dismutase 3, extracellular
Identifiers
SymbolSOD3
Entrez6649
HUGO11181
OMIM185490
RefSeqNM_003102
UniProtP08294
Other data
EC number1.15.1.1
LocusChr. 4 pter-q21

WikiDoc Resources for Superoxide dismutase

Articles

Most recent articles on Superoxide dismutase

Most cited articles on Superoxide dismutase

Review articles on Superoxide dismutase

Articles on Superoxide dismutase in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Superoxide dismutase

Images of Superoxide dismutase

Photos of Superoxide dismutase

Podcasts & MP3s on Superoxide dismutase

Videos on Superoxide dismutase

Evidence Based Medicine

Cochrane Collaboration on Superoxide dismutase

Bandolier on Superoxide dismutase

TRIP on Superoxide dismutase

Clinical Trials

Ongoing Trials on Superoxide dismutase at Clinical Trials.gov

Trial results on Superoxide dismutase

Clinical Trials on Superoxide dismutase at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Superoxide dismutase

NICE Guidance on Superoxide dismutase

NHS PRODIGY Guidance

FDA on Superoxide dismutase

CDC on Superoxide dismutase

Books

Books on Superoxide dismutase

News

Superoxide dismutase in the news

Be alerted to news on Superoxide dismutase

News trends on Superoxide dismutase

Commentary

Blogs on Superoxide dismutase

Definitions

Definitions of Superoxide dismutase

Patient Resources / Community

Patient resources on Superoxide dismutase

Discussion groups on Superoxide dismutase

Patient Handouts on Superoxide dismutase

Directions to Hospitals Treating Superoxide dismutase

Risk calculators and risk factors for Superoxide dismutase

Healthcare Provider Resources

Symptoms of Superoxide dismutase

Causes & Risk Factors for Superoxide dismutase

Diagnostic studies for Superoxide dismutase

Treatment of Superoxide dismutase

Continuing Medical Education (CME)

CME Programs on Superoxide dismutase

International

Superoxide dismutase en Espanol

Superoxide dismutase en Francais

Business

Superoxide dismutase in the Marketplace

Patents on Superoxide dismutase

Experimental / Informatics

List of terms related to Superoxide dismutase

Overview

The enzyme superoxide dismutase (SOD, EC 1.15.1.1), catalyzes the dismutation of superoxide into oxygen and hydrogen peroxide. As such, it is an important antioxidant defense in nearly all cells exposed to oxygen. One of the exceedingly rare exceptions is Lactobacillus plantarum and related lactobacilli, which use a different mechanism.

Reaction

The SOD-catalysed dismutation of superoxide may be written with the following half-reactions :

  • M(n+1)+ − SOD + O2 → Mn+ − SOD + O2
  • Mn+ − SOD + O2 + 2H+ → M(n+1)+ − SOD + H2O2.

where M = Cu (n=1) ; Mn (n=2) ; Fe (n=2) ; Ni (n=2).

In this reaction the oxidation state of the metal cation oscillates between n and n+1.

Types

General

SOD was discovered by Irwin Fridovich and Joe McCord, which prior were known as several metalloproteins with unknown function (for example, CuZnSOD was known as erythrocuprein). Several common forms of SOD exist: they are proteins cofactored with copper and zinc, or manganese, iron, or nickel.

  • The cytosols of virtually all eukaryotic cells contain an SOD enzyme with copper and zinc (Cu-Zn-SOD). (For example, Cu-Zn-SOD available commercially is normally purified from the bovine erythrocytes: PDB 1SXA, EC 1.15.1.1). The Cu-Zn enzyme is a homodimer of molecular weight 32,500. The two subunits are joined primarily by hydrophobic and electrostatic interactions. The ligands of copper and zinc are histidine side chains.
  • Chicken liver (and nearly all other) mitochondria, and many bacteria (such as E. coli) contain a form with manganese (Mn-SOD). (For example, the Mn-SOD found in a human mitochondrion: PDB 1N0J, EC 1.15.1.1). The ligands of the manganese ions are 3 histidine side chains, an aspartate side chain and a water molecule or hydroxy ligand depending on the Mn oxidation state (respectively II and III).
  • E. coli and many other bacteria also contain a form of the enzyme with iron (Fe-SOD); some bacteria contain Fe-SOD, others Mn-SOD, and some contain both. (For the E. coli Fe-SOD: PDB 1ISA, EC 1.15.1.1). The active sites of Mn and Fe superoxide dismutases contain the same type of amino acids side chains.
Structure of the active site of human superoxide dismutase 2

Human

In humans, three forms of superoxide dismutase are present. SOD1 is located in the cytoplasm, SOD2 in the mitochondria and SOD3 is extracellular. The first is a dimer (consists of two units), while the others are tetramers (four subunits). SOD1 and SOD3 contain copper and zinc, while SOD2 has manganese in its reactive centre. The genes are located on chromosomes 21, 6 and 4, respectively (21q22.1, 6q25.3 and 4p15.3-p15.1).

A microtiter plate assay for SOD is available[1].

Biochemistry

Simply-stated, SOD outcompetes damaging reactions of superoxide, thus protecting the cell from superoxide toxicity. The reaction of superoxide with non-radicals is spin forbidden. In biological systems, this means its main reactions are with itself (dismutation) or with another biological radical such as nitric oxide (NO). The superoxide anion radical (O2-) spontaneously dismutes to O2 and hydrogen peroxide (H2O2) quite rapidly (~105 M-1 s-1 at pH 7). SOD is biologically necessary because superoxide reacts even faster with certain targets such as NO radical, which makes peroxynitrite. Similarly, the dismutation rate is second order with respect to initial superoxide concentration. Thus, the half-life of superoxide, although very short at high concentrations (e.g. 0.05 seconds at 0.1mM) is actually quite long at low concentrations (e.g. 14 hours at 0.1 nM). In contrast, the reaction of superoxide with SOD is first order with respect to superoxide concentration. Moreover, superoxide has the fastest turnover number (reaction rate with its substrate) of any known enzyme (~109 M-1 s-1), this reaction being only limited by the frequency of collision between itself and superoxide. That is, the reaction rate is "diffusion limited".

Physiology

Superoxide is one of the main reactive oxygen species in the cell and as such, SOD serves a key antioxidant role. The physiological importance of SODs is illustrated by the severe pathologies evident in mice genetically engineered to lack these enzymes. Mice lacking SOD2 die several days after birth, amidst massive oxidative stress[2]. Mice lacking SOD1 develop a wide range of pathologies, including hepatocellular carcinoma[3], an acceleration of age-related muscle mass loss[4], an earlier incidence of cataracts and a reduced lifespan. Mice lacking SOD3 do not show any obvious defects and exhibit a normal lifespan[5].

Role in disease

Mutations in the first SOD enzyme (SOD1) have been linked to familial amyotrophic lateral sclerosis (ALS, a form of motor neuron disease). The other two types have not been linked to any human diseases, however, in mice inactivation of SOD2 causes perinatal lethality[2] and inactivation of SOD1 causes hepatocellular carcinoma[3]. Mutations in SOD1 can cause familial ALS, by a mechanism that is presently not understood, but not due to loss of enzymatic activity. Overexpression of SOD1 has been linked to Down's syndrome[6]. The veterinary antiinflammatory drug "Orgotein" is purified bovine liver superoxide dismutase.

Delivery systems

Superoxide dismutase is effective as a nutritional supplement when bound to the polymeric films of wheat matrix gliadin (a delivery method also known as glisodin). Gliadin is an ideal carrier because it protects SOD from stomach acid and enzymes found in the digestive system which break down its molecular structure. This has been established in a variety of animal studies and human clinical trials, in which SOD's generally high antioxidant capacity is kept intact under a variety of conditions.

Cosmetic uses

SOD is used in cosmetic products to reduce free radical damage to skin, for example to reduce fibrosis following radiation for breast cancer. Studies of this must be regarded as tentative however, as there were not adequate controls in the study including a lack of randomization, double-blinding or placebo.[7] Superoxide dismutase is known to reverse fibrosis, perhaps through reversion of myofibroblasts back to fibroblasts.[8]

References

  1. A.V. Peskin, C.C. Winterbourn (2000). "A microtiter plate assay for superoxide dismutase using a water-soluble tetrazolium salt (WST-1)". Clinica Chimica Acta. 293: 157–166.
  2. 2.0 2.1 Li, Y.; et al. (1995). "Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase". Nat. Genet. 11: 376–381.
  3. 3.0 3.1 Elchuri, S.; et al. (2005). "CuZnSOD deficiency leads to persistent and widespread oxidative damage and hepatocarcinogenesis later in life". Oncogene. 24: 367–380.
  4. Muller, F. L.; et al. (2006). "Absence of CuZn superoxide dismutase leads to elevated oxidative stress and acceleration of age-dependent skeletal muscle atrophy". Free Radic. Biol. Med. 40: 1993–2004.
  5. Sentman, M. L.; et al. (2006). "Phenotypes of mice lacking extracellular superoxide dismutase and copper- and zinc-containing superoxide dismutase". J. Biol. Chem. 281: 6904–6909. doi:10.1074/jbc.M510764200.
  6. Groner, Y.; et al. (1994). "Cell damage by excess CuZnSOD and Down's syndrome". Biomed Pharmacother. 48: 231–40. PMID 7999984.
  7. Campana, F. (2004). "Topical superoxide dismutase reduces post-irradiation breast cancer fibrosis" (available free). J. Cell. Mol. Med. 8 (1): 109–116. PMID 15090266.
  8. Vozenin-Brotons MC (January 1 2001). "Antifibrotic action of Cu/Zn SOD is mediated by TGF-beta1 repression and phenotypic reversion of myofibroblasts". Free Radic Biol Med. Elsevier. 30 (1): 30–42. PMID 11134893. Unknown parameter |coauthors= ignored (help); Check date values in: |date= (help); |access-date= requires |url= (help)

See also

External links

Template:SIB

de:Superoxiddismutase it:Superossido dismutasi he:סופראוקסיד דיסמוטאז nl:Superoxide dismutase

Template:Jb1 Template:WH Template:WS